Ocugen (OCGN) Competitors

CureVac (NASDAQ:CVAC) and Ocugen (NASDAQ:OCGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, community ranking, risk and media sentiment.

Is CVAC or OCGN more profitable?

CureVac has a net margin of 20.72% compared to Ocugen's net margin of -532.51%. CureVac's return on equity of 21.98% beat Ocugen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CureVac	20.72%	21.98%	15.72%
Ocugen	-532.51%	-154.75%	-90.79%

Do insiders and institutionals have more ownership in CVAC or OCGN?

17.3% of CureVac shares are owned by institutional investors. Comparatively, 10.3% of Ocugen shares are owned by institutional investors. 2.2% of CureVac shares are owned by company insiders. Comparatively, 4.4% of Ocugen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Which has higher earnings and valuation, CVAC or OCGN?

Ocugen has lower revenue, but higher earnings than CureVac. Ocugen is trading at a lower price-to-earnings ratio than CureVac, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CureVac	$535.18M	1.74	-$281.58M	$0.82	5.07
Ocugen	$4.52M	59.02	-$63.08M	-$0.19	-4.81

Does the MarketBeat Community prefer CVAC or OCGN?

Ocugen received 88 more outperform votes than CureVac when rated by MarketBeat users. Likewise, 71.43% of users gave Ocugen an outperform vote while only 56.25% of users gave CureVac an outperform vote.

Company	Underperform	Outperform
CureVac	Outperform Votes 27 56.25%	Underperform Votes 21 43.75%
Ocugen	Outperform Votes 115 71.43%	Underperform Votes 46 28.57%

Which has more volatility and risk, CVAC or OCGN?

CureVac has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500. Comparatively, Ocugen has a beta of 4.21, indicating that its stock price is 321% more volatile than the S&P 500.

Does the media favor CVAC or OCGN?

In the previous week, CureVac had 1 more articles in the media than Ocugen. MarketBeat recorded 4 mentions for CureVac and 3 mentions for Ocugen. Ocugen's average media sentiment score of 1.26 beat CureVac's score of 0.10 indicating that Ocugen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CureVac	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ocugen	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend CVAC or OCGN?

CureVac currently has a consensus price target of $14.00, indicating a potential upside of 236.54%. Ocugen has a consensus price target of $6.00, indicating a potential upside of 556.53%. Given Ocugen's higher possible upside, analysts plainly believe Ocugen is more favorable than CureVac.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CureVac	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Ocugen	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Ocugen beats CureVac on 9 of the 17 factors compared between the two stocks.